Navigation Links
eBioscience Acquires Bender MedSystems; Business Combination Adds Cutting-Edge Product Lines and Expands International Operations
Date:10/26/2009

SAN DIEGO and VIENNA, Oct. 27 /PRNewswire/ -- eBioscience Corporation today announced that it has acquired privately held immunoassay technology pioneer Bender MedSystems GmbH in an all cash transaction. The acquisition will provide eBioscience with over 1,000 high profile immunology and oncology products including the Instant ELISA® and FlowCytomix(TM) brands that target the life sciences and diagnostics markets.

"Bender MedSystems provides us with a cutting-edge technology platform that, when combined with many of eBioscience's leading cell analysis research and diagnostic products, will facilitate the accelerated development and commercialization of breakthrough innovations," explained eBioscience CEO, Todd R. Nelson Ph.D. "Bender MedSystems proprietary Instant ELISA® technology and associated product lines confer several major competitive advantages over existing technologies including increased sensitivity, significantly simplified handling and reduced analysis time," added Michael Schaude Ph.D., CEO of Bender MedSystems.

Bender MedSystems' novel bead based multiplexing technology and products, marketed and sold under the FlowCytomix(TM) brand, allow researchers to analyze simultaneously up to 20 proteins in a single reaction. This highly scalable technology platform can be combined with many of eBioscience's existing technologies that the company intends to use in the development of a significant number of expanded sets of cell analysis product lines.

"The FlowCytomix(TM) reagents are designed to run on existing flow cytometry instruments, allowing eBioscience to take full advantage of our current commercial channel without having to invest into an instrument platform. Accordingly, the technology represents an exceptional opportunity for us to increase our presence within the multiplexing segment of the immunoassay market," Dr. Nelson commented.

The Bender MedSystems' acquisition builds on eBios
'/>"/>

SOURCE eBioscience Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
2. eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008
3. eBioscience Corporation Acquires NatuTec GmbH
4. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
5. Neogen Acquires Kane Enterprises
6. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
7. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
8. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
9. NSF International Acquires David Begg Associates
10. United BioSource Acquires Caro Research, Leader in Simulation Modeling
11. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... , July 30, 2014 Regulus ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended June ... U.S. financial markets close. Regulus will ... 6, 2014, at 5:00 pm Eastern Daylight Time to ...
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron Pharmaceuticals, ... SNY) today announced that the Companies intend to use ... disease priority review voucher in connection with the Biologics ... voucher entitles the holder to designate a BLA for ... from the filing date instead of the standard 10-month ...
(Date:7/30/2014)... W. R. Grace & Co. (NYSE: ... REVELERIS® Prep purification system , a dual-mode instrument ... researchers to perform both flash and preparative liquid ... the REVELERIS® Prep purification system, researchers can easily ... a simple touch of the screen, giving them ...
(Date:7/30/2014)... July 30, 2014  Decision Resources Group finds ... directors in the United States ... market penetration will be the level of savings ... the expected lower cost to patients. Payers plan ... meet their pricing expectations in order to encourage ...
Breaking Biology Technology:Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Grace Launches New REVELERIS® Prep Purification System 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3
... GAMMAGARD LIQUID and GAMMAGARD S/D, [Immune Globulin Intravenous ... Ill., Aug. 22 Baxter International,Inc. (NYSE: ... GARDian, an innovative,program that helps provide continued access ... [Immune Globulin Intravenous (Human)],(IGIV). IGIV products like GAMMAGARD ...
... 22 ATS Medical, Inc.,(Nasdaq: ATSI ), ... services, today announced that the US Food and ... begin marketing,additional sizes of its line of ATS ... http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ) Michael Dale, Chairman and Chief ...
... New Ballot Initiative to Pursue Cures for Patients, ... without involving controversial Human Cloning, WASHINGTON, Aug. 22 ... ensure that taxpayer funds,support cures for patients, without involving human ... issued the,following statement on the new initiative, Cures Without Cloning. ...
Cached Biology Technology:Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 2Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 3Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 4Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 5Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 6Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 7Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 8Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients 9ATS Medical Expands Open Pivot Heart Valve Offerings 2
(Date:7/30/2014)... by the Red Queen in Lewis Carroll,s Through ... Illinois and National University of Singapore improved a ... evolve over decades to millions of years. , ... for competition, incorporates the "Red Queen Effect," an ... the 1970s, which suggests that organisms must constantly ...
(Date:7/30/2014)... octopus protected and tended her eggs until they hatched ... 30, 2014 in the open-access journal PLOS ONE ... Institute and colleagues. , Octopuses typically have a single ... and take care of their fertilized eggs until they ... 1 to 3 months, but little is known about ...
(Date:7/30/2014)... American Chemical Society (ACS) announced today that David L. ... ACS Biomaterials Science & Engineering as editor-in-chief. With ... the new journal will feature high-quality research in the ... or naturally derived materials that interact with living or ... it reflects the tremendous growth in the field of ...
Breaking Biology News(10 mins):Classic Lewis Carroll character inspires new ecological model 2Classic Lewis Carroll character inspires new ecological model 3Deep-sea octopus has longest-known egg-brooding period 2ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor 2
... are closing in on finding an effective bait to ... beetle, which is now killing not only lodgepole pine ... and Canada Research Chair in Forest Entomology in the ... investigating pheromones emitted by the pest in North America,s ...
... of New England (Australia) and the Royal Botanic Gardens ... species of sedge from south-western Tasmania. A small clumping ... mountains including Mount Field and Mount Sprent. It is ... essentially restricted to alpine vegetation. At less than seven ...
... professor is developing a comprehensive data system that can ... by providing them with access to chemical toxicity information. ... is building the "automated profiling system" from existing bioassay ... profiles can help scientists who are seeking information on ...
Cached Biology News:Bait research focused on outsmarting destructive beetle 2Tasmania home to first alpine sword-sedge 2Toxicity database under development at Rutgers-Camden 2